woman heading NAFDAC

“NAFDAC must approve COVID-19 vaccines before use”, says DG

The Director-General, National Agency for Food and Drug Administration and Control, Prof. Mojisola Adeyeye, issued a warning asking Nigerians not to take any vaccine except it has been tested by NAFDAC.

Adeyeye also stated that the World Health Organisation’s approval of the vaccine is not adequate enough to rely on. She mentioned that the regulatory agency needs to certify if the vaccine is safe for use before it should be taken.

READ ALSO: EURO TO NAIRA EXCHANGE RATE.

novel corona virus

She said, “The WHO will say that unless the regulatory agency of a country approves a vaccine, it should not be used. WHO is not a regulatory agency that will approve and say use, they are there to guide and give regulatory agencies more confidence.”

“If a product is already on WHO emergency use listing, the regulatory agency will still look at the application. That doesn’t mean we just pass it like that, we will have to read it within the context of our environment. No vaccine or commodity can be used unless it passes through NAFDAC in Nigeria.”

READ ALSO: CBN EXCHANGE RATE DOLLAR TO NAIRA.

“Vaccines should not be ordered by any company or corporation. The companies that manufacture the vaccines if they are genuine companies know they have to submit their application to NAFDAC.”

“No government establishment or agencies should order COVID-19 vaccines without confirming from NAFDAC if the vaccine has been approved.”She said the agency was discussing with manufactures of candidate COVID-19 vaccines concerning potential Emergency Use Authorisation, registration or licensing of their product as the case may be.“The agency assures applicants that if phase three clinical data are very convincing and robust with regards to safety and efficacy and the vaccine has been submitted for WHO for Emergency Use Listing, NAFDAC will welcome the application for Emergency Use Authorisation in Nigeria,” Adeyeye said.

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Share on linkedin
LinkedIn

Related Posts